FindTrial
Sign In

Study of searching of Alzheimer's type dementia using the Autologous adipose tissue-derived mesenchymal stem cells

Study of searching of Alzheimer's type dementia using the Autologous adipose tissue-derived mesenchymal stem cells - Study of searching of Alzheimer's type dementia using the Autologous adipose tissue-derived mesenchymal stem cells

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000035578
Enrollment
32
Registered
2019-01-18
Start date
2019-06-03
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer&#39

Interventions

Adipose derived mesenchymal stem cell infusion therapy (48weeks)

Sponsors

JAPAN ANGEL STEMCELL
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: -Persons diagnosed with F3 Probable AD ICD-10 diagnostic criteria using -MMSE score of 15 to 24 -The patient who can perform fat cell collection of the required amount

Exclusion criteria

Exclusion criteria: -Patient of deliriousness at the time of screening -Patient of a dangerously ill organ disorder -Patient of severe diabetes mellitus, severe cardiac failure and kidney failure

Design outcomes

Primary

MeasureTime frame
Baseline of ADAS-Jcog(Alzheimer's Disease Assessment Scale-cognitive component Japanese version) and change until every 8 weeks and 48weeks—

Secondary

MeasureTime frame
-Baseline of MMSE and change of 48 weeks -Baseline of ADL behavior Cognition Dimentia Scale(ABC dimentia Scale) and change until every 8 weeks and 48weeks—

Countries

Japan

Contacts

Public ContactChiaki Kudoh

Kudoh Chiaki Neurosurgery clinic Director

kudoh@kudohchiaki.com03-5767-0226

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026